MANILA — The doctor on the phone asked Ratish Sharma how old he was and how long he had been taking Telma 40. That was it. The order went through.
A strip of blood pressure medication arrived at his door in under ten minutes. Sharma did not have a prescription.
He did not need one. That is the reality of buying prescription drugs through quick-commerce apps in the Philippines today. And doctors are alarmed.
Physicians and internal medicine specialists who spoke to Times Now Digital say the system is not working. The checks meant to replace a doctor’s consultation are dangerously thin.
A few basic questions — age, duration of use — do not amount to a medical assessment. They do not evaluate kidney function. They do not check for drug interactions.
They do not confirm whether the patient actually has the condition the drug is meant to treat. “Could a brief verification call replace a doctor’s assessment of a patient’s medical history, kidney function, current medications and whether the drug is appropriate in the first place?” the report asks. The doctors’ answer, implicitly, is no. Telma 40 contains telmisartan, an angiotensin II receptor blocker.
It lowers blood pressure. It also affects the kidneys.
Patients with renal impairment need different doses or different drugs entirely. A quick phone call cannot catch that. The platform Sharma used did follow its own rules.
An in-house doctor called. Sharma kept his prescription handy — not that he had one.
The doctor asked questions. The order was approved. On paper, the process ran correctly.
But the process itself is the problem. Quick-commerce platforms are expanding beyond groceries into healthcare. They offer speed.
For elderly patients, for people with chronic illnesses, for anyone who struggles to reach a pharmacy, that speed is real. But the trade-off is risk.
Leading doctors say medicines should become easier to access. They do not say prescription safeguards should be bypassed. The distinction matters.
Sharma’s case is not hypothetical. If someone without hypertension answered those same questions convincingly, they could obtain a prescription-only medicine.
The verification call does not verify much. It does not measure blood pressure. It does not review medical records.
It does not confirm identity. The problem is structural. The apps are designed for convenience.
Healthcare is not always convenient. It requires time, attention, and clinical judgment.
A ten-minute delivery cannot substitute for a ten-minute consultation. Doctors are not opposed to technology. They are opposed to shortcuts that put patients at risk.
A patient who takes Telma 40 without needing it could experience hypotension, dizziness, fainting. A patient who needs a different drug entirely could suffer a stroke or heart attack while taking the wrong one.
The phone call does not prevent that. The report does not name the app Sharma used. It does not say what happened after the delivery.
It does not offer policy recommendations. It simply raises the question: Are these checks sufficient? The doctors’ answer is clear.
For now, the apps keep expanding. The phone calls keep happening.
The medications keep arriving at doorsteps. And the safeguards remain thin. That is the story.
